Literature DB >> 31276687

Physical training improves exercise tolerance, cardiac function and promotes changes in neurotrophins levels in chagasic mice.

Rafael Leite Alves1, Bárbara Ramalho Ladeira Cardoso1, Isalira Peroba Rezende Ramos2, Bruna da Silva Oliveira1, Mara Lívia Dos Santos1, Aline Silva de Miranda1, Tatiane Cristine Silva de Almeida1, Maria Aparecida Ribeiro Vieira3, Fabiana Simão Machado4, Anderson José Ferreira5, Gleide Fernandes de Avelar1.   

Abstract

AIMS: To investigate the effects of moderate aerobic physical training on cardiac function and morphology as well as on the levels of glial cell-derived neurotrophic factor (GDNF), nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) of animals infected with the Y strain of Trypanosoma cruzi. MAIN
METHODS: Twenty-eight male C57BL/6 mice were distributed into 4 groups: sedentary control (SC), trained control (TC), sedentary infected (CHC) and trained infected (CHT). The infection was performed by intraperitoneal injection of trypomastigote forms and the animals were adapted to treadmill in the week before the beginning of the training protocol, initiated 45 days post infection. Maximal exercise test (TEM) was performed at the baseline as well as at the end of the 4th, 8th and 12th weeks of training. At the end of the 12th week, all animals were evaluated for cardiac morphology and function by echocardiography. KEY
FINDINGS: CHC group showed a larger area of right ventricle (RVA), increased end-systolic volume and reduction in ejection fraction (EF), stroke volume (SV), cardiac output (CO) and fractional area change (FAC). The training reduced the RVA and improved the FAC of chagasic animals. GDNF level was higher in TC and CHC groups compared to SC in heart and BDNF levels were higher in CHC compared to SC in heart and serum. SIGNIFICANCE: Physical training ameliorated the cardiac function of infected animals and promoted adjusts in BDNF and GDNF levels. These findings evidenced these neurotrophins as possible biomarkers of cardiac function responsive to exercise stimulus.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain derived neurotrophic factor (BDNF); Cardiac function; Chagas' disease; Chagasic cardiomyopathy; Exercise training; Glial cell-derived neurotrophic factor (GDNF); Nerve growth factor (NGF); Neurotrophins

Mesh:

Substances:

Year:  2019        PMID: 31276687     DOI: 10.1016/j.lfs.2019.116629

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease.

Authors:  Yasmin Pedra-Rezende; Juliana M C Barbosa; Ana Cristina S Bombaça; Luiza Dantas-Pereira; Daniel Gibaldi; Glaucia Vilar-Pereira; Hílton Antônio Mata Dos Santos; Isalira Peroba Ramos; Natália Lins Silva-Gomes; Otacilio C Moreira; Joseli Lannes-Vieira; Rubem F S Menna-Barreto
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

2.  Moderate Aerobic Exercise Regulates Follicular Dysfunction by Initiating Brain-Derived Neurotrophic Factor (BDNF)-Mediated Anti-Apoptotic Signaling Pathways in Polycystic Ovary Syndrome.

Authors:  Yaling Zhang; Dejian Chen; Daojuan Wang; Lei Wang; Yajing Weng; Hongwei Wang; Xiaoke Wu; Yong Wang
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

Review 3.  Systematic Review and Meta-Analysis of Endurance Exercise Training Protocols for Mice.

Authors:  Michael P Massett; Caitlyn Matejka; Hyoseon Kim
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566

4.  Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis.

Authors:  Marcela de Souza-Basqueira; Roberto Marques Ribeiro; Léa Campos de Oliveira; Carlos Henrique Valente Moreira; Roberta Cristina Ruedas Martins; Diego Castillo Franco; Pâmela Pontes Penas Amado; Marcia Pinto Alves Mayer; Ester Cerdeira Sabino
Journal:  Front Cell Infect Microbiol       Date:  2020-08-19       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.